share_log

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Benzinga ·  Nov 21, 2023 08:06

Gainers

  • SILO Pharma (NASDAQ:SILO) shares increased by 36.2% to $2.22 during Tuesday's pre-market session. The company's market cap stands at $6.9 million.
  • TRACON Pharma (NASDAQ:TCON) shares increased by 30.02% to $0.23. The market value of their outstanding shares is at $7.0 million.
  • Fresh2 Group (NASDAQ:FRES) shares increased by 28.4% to $1.22. The market value of their outstanding shares is at $17.9 million.
  • Brainstorm Cell (NASDAQ:BCLI) shares increased by 22.03% to $0.22. The company's market cap stands at $10.7 million.
  • TC BioPharm (Holdings) (NASDAQ:TCBP) shares moved upwards by 19.23% to $0.62. The company's market cap stands at $5.8 million.
  • Connect Biopharma Hldgs (NASDAQ:CNTB) stock increased by 17.47% to $2.42. The market value of their outstanding shares is at $133.2 million.

Losers

  • MorphoSys (NASDAQ:MOR) shares fell 24.1% to $4.45 during Tuesday's pre-market session. The market value of their outstanding shares is at $608.2 million. As per the press release, Q3 earnings came out 4 days ago.
  • Alzamend Neuro (NASDAQ:ALZN) shares declined by 13.67% to $1.2. The market value of their outstanding shares is at $7.7 million.
  • Enzo Biochem (NYSE:ENZ) stock fell 13.39% to $1.1. The market value of their outstanding shares is at $55.5 million.
  • Cardio Diagnostics Hldgs (NASDAQ:CDIO) shares decreased by 12.22% to $1.94. The company's market cap stands at $36.3 million.
  • Sharps Technology (NASDAQ:STSS) shares decreased by 11.91% to $0.41. The company's market cap stands at $6.2 million.
  • Nemaura Medical (NASDAQ:NMRD) stock fell 10.17% to $0.21. The market value of their outstanding shares is at $6.1 million. See Also:

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment